Literature DB >> 15955063

Interaction of human stefin B in the prefibrillar oligomeric form with membranes. Correlation with cellular toxicity.

Gregor Anderluh1, Ion Gutierrez-Aguirre, Sabina Rabzelj, Slavko Ceru, Natasa Kopitar-Jerala, Peter Macek, Vito Turk, Eva Zerovnik.   

Abstract

Protein aggregation is central to most neurodegenerative diseases, as shown by familial case studies and by animal models. A modified 'amyloid cascade' hypothesis for Alzheimer's disease states that prefibrillar oligomers, also called amyloid-beta-derived diffusible ligands or globular oligomers, are the responsible toxic agent. It has been proposed that these oligomeric species, as shown for amyloid-beta, beta2-microglobulin or prion fragments, exert toxicity by forming pores in membranes, initiating a cascade of detrimental events for the cell. Interaction of granular aggregates and globular oligomers of an amyloidogenic protein, human stefin B, with model lipid membranes and monolayers was studied. Prefibrillar oligomers/aggregates of stefin B are shown to cause concentration-dependent membrane leaking, in contrast to the homologous stefin A. Prefibrillar oligomers/aggregates of stefin B also increase the surface pressure at an air-water interface, i.e. they have amphipathic character and are surface seeking. In addition, they show stronger interaction with 1,2-dioleoyl-sn-glycero-3-phosphocholine and 1,2-dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] monolayers than native stefin A or nonaggregated stefin B. Prefibrillar aggregates interact predominantly with acidic phospholipids, such as dioleoylphosphatidylglycerol or dipalmitoylphosphatidylserine, as shown by calcein release experiments and surface plasmon resonance. The same preparations are toxic to neuroblastoma cells, as determined by the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay, again in contrast to the homologue stefin A, which does not aggregate under any of the conditions studied. This study is aimed to contribute to the general model of cellular toxicity induced by prefibrillar oligomers of amyloidogenic proteins, not necessarily involved in pathology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15955063     DOI: 10.1111/j.1742-4658.2005.04717.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  14 in total

1.  Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.

Authors:  Dun-Sheng Yang; Philip Stavrides; Panaiyur S Mohan; Susmita Kaushik; Asok Kumar; Masuo Ohno; Stephen D Schmidt; Daniel Wesson; Urmi Bandyopadhyay; Ying Jiang; Monika Pawlik; Corrinne M Peterhoff; Austin J Yang; Donald A Wilson; Peter St George-Hyslop; David Westaway; Paul M Mathews; Efrat Levy; Ana M Cuervo; Ralph A Nixon
Journal:  Brain       Date:  2011-01       Impact factor: 13.501

2.  In vitro study of stability and amyloid-fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1.

Authors:  Sabina Rabzelj; Vito Turk; Eva Zerovnik
Journal:  Protein Sci       Date:  2005-09-09       Impact factor: 6.725

3.  Hen lysozyme amyloid fibrils induce aggregation of erythrocytes and lipid vesicles.

Authors:  Nitin Chaudhary; Ramakrishnan Nagaraj
Journal:  Mol Cell Biochem       Date:  2009-03-26       Impact factor: 3.396

4.  Interaction between oligomers of stefin B and amyloid-beta in vitro and in cells.

Authors:  Katja Skerget; Ajda Taler-Vercic; Andrej Bavdek; Vesna Hodnik; Slavko Ceru; Magda Tusek-Znidaric; Tiina Kumm; Didier Pitsi; Marusa Pompe-Novak; Peep Palumaa; Salvador Soriano; Natasa Kopitar-Jerala; Vito Turk; Gregor Anderluh; Eva Zerovnik
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

5.  Natively folded HypF-N and its early amyloid aggregates interact with phospholipid monolayers and destabilize supported phospholipid bilayers.

Authors:  Claudio Canale; Silvia Torrassa; Pasquale Rispoli; Annalisa Relini; Ranieri Rolandi; Monica Bucciantini; Massimo Stefani; Alessandra Gliozzi
Journal:  Biophys J       Date:  2006-09-22       Impact factor: 4.033

6.  Mistic: cellular localization, solution behavior, polymerization, and fibril formation.

Authors:  Hay Dvir; Matthew E Lundberg; Samir K Maji; Roland Riek; Senyon Choe
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

7.  Differentiation increases the resistance of neuronal cells to amyloid toxicity.

Authors:  Cristina Cecchi; Anna Pensalfini; Gianfranco Liguri; Serena Baglioni; Claudia Fiorillo; Simone Guadagna; Mariagioia Zampagni; Lucia Formigli; Daniele Nosi; Massimo Stefani
Journal:  Neurochem Res       Date:  2008-02-29       Impact factor: 3.996

8.  Pore formation by human stefin B in its native and oligomeric states and the consequent amyloid induced toxicity.

Authors:  Gregor Anderluh; Eva Zerovnik
Journal:  Front Mol Neurosci       Date:  2012-08-02       Impact factor: 5.639

9.  Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants.

Authors:  Mira Polajnar; Slavko Ceru; Nataša Kopitar-Jerala; Eva Zerovnik
Journal:  Front Mol Neurosci       Date:  2012-08-24       Impact factor: 5.639

10.  Increased expression of stefin B in the nucleus of T98G astrocytoma cells delays caspase activation.

Authors:  Tao Sun; Vito Turk; Boris Turk; Nataša Kopitar-Jerala
Journal:  Front Mol Neurosci       Date:  2012-09-14       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.